IgM natural antibody against an asialooligosaccharide, gangliotetraose (Gg4), sensitizes HIV-I infected cells for cytolysis by homologous complement

International Immunology

Volumn 8, Issue 1, 1996, Pages 153-158

  Wu, Xiaoshan ^a,b   Okada, Noriko ^a   Iwamori, Masao ^c   Okada, Hidechika ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b Fukushimura Hospital   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

HIV; IgM natural antibody; Membrane complement inhibitors

Indexed keywords

DECAY ACCELERATING FACTOR; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN M; MEMBRANE COFACTOR PROTEIN; OLIGOSACCHARIDE;

ARTICLE; CELL MEMBRANE; COMPLEMENT ACTIVATION; CYTOLYSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; VIRUS CELL INTERACTION;

ANTIGENS, CD59; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT PATHWAY, CLASSICAL; HIV INFECTIONS; HUMANS; IMMUNITY, NATURAL; IMMUNOGLOBULIN M; OLIGOSACCHARIDES;

EID: 0030060428     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/8.1.153     Document Type: Article

References (19)

1. Ebenbichler, C. F., Thielens, N. M , Vornhagen, R., Marschang, R, Arlaud, G J. and Dierich, M. P 1991. Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the Iransmembrane glycoprotein gp41. J Exp. Med 174:1417.
2. Sual, C., M. Kirschfink, M. Kropelin, V. Daniel and G Opelz. 1994 Complement activation by recombinant HIV-1 glycoprotein gp 120. J. Immunol. 152.6028.
3. Okada, H., Tanaka, H. and Okada, N. 1983. Prevention of complement activation on the homologous cell membrane of nucleated cells as well as errythrocytes. Eur. J. Immunol. 13:340.
4. Nicholson-Weller, A , Burge, J., Fearon, D. T., Weller, P. F. and Austen, K. F. 1982. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J. Immunol. 129:184.
5. Seya, T , Turner, J. R and Atkinson, J. P 1986. Purification and characterization of a membrane protein (gp45-70) which is a cofactor for cleavage of C3b and C4b J. Exp. Med 163:837
6. Okada, N., Harada, R , Fujita, T and Okada, H 1989. A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement. Int. Immunol. 1.205.
7. Davies, A , Simmons, D L , Hale, G., Harrson, R A , Tighe, H., Lachmann, R J. and Waldmann, H. 1989 CD59, an ly-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J. Exp. Med. 170.637
8. Okada, H., Nagami, Y., Takahashi, K , Okada, N., Hideshima, T, Takizawa, H and Kondo, J 1989. 20 kDa homologous restriction factor of complement resembles T cell activating protein. Biochem. Biophys Res. Commun 162:1553
9. Weiss, L., Okada, N., Haeffner-Cavaillon, N., Hatton, T., Faucher, C , Kazatchkine, M. D. and Okada, H. 1992 Decreased expression of the membrane inhibitor of complement-mediated cytolysis CD59 on T lymphocytes of HIV-infected patients AIDS 6.379.
10. Okada, N., Yasuda, T. and Okada, H. 1982. Restriction of alternative complement pathway activation by sialosylglycolipids Nature 299:261
11. Borsos, T. and Rapp, H. J. 1965 Complement fixation on cell surfaces by 19S and 7S antibodies Science 150:505
12. Jones, P. C., Sze, L L., Morton, D L and Ine, R F 1980. Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen. J Natl Cancer Inst. 66:249.
13. Matsushita, S., Riber-Guroff, M., Rusche, J., Koito, A., Hatton, T, Hosino, H., Javaherian, K , Takatsuki, K and Putney, S. 1988 Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope. J Virol 62:2107
14. Yonehara, S., Ishii, A. and Yonehara, M. 1989. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen codownregulated with the receptor of tumor necrosis factor. J. Exp. Med 169:1747.
15. Fujita, T, Inoue, T., Ogawa, K. and Tamura, N 1987 The mechanisms of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb. J Exp Med. 166:1211.
16. Seya,T., Hara, T., Matsumoto, M. and Akedo, H 1990 Quantitative analysis of membrane cofactor protein (MCP) of complement high expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation. J Immunol 145:238.
17. Thomas, P. S. 1983 Hybridization of denatured RNA transferred or dotted to nitrocellulose paper. Methods Enzymol 100:255
18. Kumar, S , James, M V , Barbara, A P and Corrado, B 1993. Expression of RNAs for complement inhibitors in human tissues and tumors Cancer Res 53 348
19. Purcell, D F. J , Russel, S. M., Deacon, N. J., Brown, M. A , Hooker, D. J. and McKenzie, I. F C. 1991 Alternatively spliced RNAs encode several isoforms of CD46 (MCP), a regulator of complement activation, Immunogenetics 33.335